Primary malignant lymphoma of the brain: Frequent abnormalities and inactivation of p14 tumor suppressor gene

Cancer Science

Volumn 96, Issue 1, 2005, Pages 38-41

  Zhang, Shu Jing ^a,b   Endo, Sumio ^a   Saito, Takafumi ^c   Kouno, Mitsuo ^d   Kuroiwa, Toshihiko ^e   Washiyama, Kazuo ^a   Kumanishi, Toshiro ^a,f  

^a NIIGATA UNIVERSITY   (Japan)

^b KAROLINSKA INSTITUTE   (Sweden)

^c NAGANO RED CROSS HOSPITAL   (Japan)

^d TOYAMA PREFECTURAL CENTRAL HOSPITAL   (Japan)

^e OSAKA MEDICAL COLLEGE   (Japan)

^f Niigata Longevity Research Institute   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P14; PROTEIN P14ARF; PROTEIN P15; PROTEIN P16; TUMOR SUPPRESSOR PROTEIN;

ADULT; AGED; ARTICLE; B CELL LYMPHOMA; BRAIN BIOPSY; BRAIN LYMPHOMA; CARCINOGENESIS; CLINICAL ARTICLE; CONTROLLED STUDY; CPG ISLAND; EXON; FEMALE; GENE DELETION; GENE INACTIVATION; GENE MUTATION; HEMIZYGOSITY; HOMOZYGOSITY; HUMAN; HUMAN CELL; HUMAN TISSUE; HYBRIDIZATION; LYMPHOMA; MALE; MISSENSE MUTATION; PATHOPHYSIOLOGY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN METHYLATION; QUANTITATIVE ANALYSIS; SIGNAL TRANSDUCTION; SOUTHERN BLOTTING; BRAIN TUMOR; DNA METHYLATION; GENETICS; MIDDLE AGED; MUTATION; NUCLEOTIDE SEQUENCE; TUMOR SUPPRESSOR GENE;

ADULT; AGED; BASE SEQUENCE; BLOTTING, SOUTHERN; BRAIN NEOPLASMS; DNA METHYLATION; FEMALE; GENES, TUMOR SUPPRESSOR; HUMANS; LYMPHOMA; MALE; MIDDLE AGED; MUTATION; TUMOR SUPPRESSOR PROTEIN P14ARF;

EID: 14144252658     PISSN: 13479032     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2005.00003.x     Document Type: Article

References (27)

1. Quelle DE, Zindy F, Ashmun RA, Sherr CJ. Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest. Cell 1995; 83: 993-1000.
2. INK4a: a gene with a dual capacity to encode unrelated proteins that inhibit cell cycle progression. Oncogene 1996; 12: 2041-4.
3. ARF. Cell 1997; 91: 555-8.
4. INK4B/MTS2- related CDK6 inhibitor, correlates with wild-type pRb function. Genes Dev 1994; 8: 2939-52.
5. Arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53. Cell 1998; 92: 713-23.
6. Zhang Y, Xiong Y, Yarbrough WG. ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways. Cell 1998; 92: 725-34.
7. Kamijo T, Weber JD, Zambetti G, Zindy F, Roussel MF, Sherr CJ. Functional and physical interactions of the ARF tumor suppressor with p53 and Mdm2. Proc Natl Acad Sci USA 1998; 95: 8292-7.
8. Martelli F, Hamilton T, Silver DP, Sharpless NE, Bardeesy N, Rokas M, DePinho RA, Livingston DM, Grossman SR. p19ARF targets certain E2F species for degradation. Proc Natl Acad Sci USA 2001; 98: 4455-60.
9. Yarbrough WG, Bessho M, Zanation A, Bisi JE, Xiong Y. Human tumor suppressor ARF impedes S-phase progression independent of p53. Cancer Res 2002; 62: 1171-7.
10. INK4a/CDKN2A tumor suppressor and its relatives. Biochim Biophys Acta 1998; 1378: F115-F177.
11. Kumanishi T, Zhang S-J, Ichikawa T, Endo S, Washiyama K. Primary malignant lymphoma of the brain: demonstration of frequent p16 and p15 gene deletions. Jpn J Cancer Res 1996; 87: 691-5.
12. Zhang S-J, Endo S, Ichikawa T, Washiyama K, Kumanishi T. Frequent deletion and 5′-CpG island methylation of the p16 gene in primary malignant lymphoma of the brain. Cancer Res 1998; 58: 1231-7.
13. INK4a genes in colon cancer. Lab Invest 2001; 81: 217-29.
14. Suci T, Tajima K, Nanba K, Wakasa H, Mikata A, Kikuchi M, Mori S, Watanabe S, Mohri N, Shamoto M, Harigaya K, Itagaki T, Matsuda M, Kirino Y, Takagi K, Fukunaga S. Some problems on the histopathological diagnosis of non-Hodgkin's malignant lymphoma-A proposal of a new type. Acta Pathol Jpn 1979; 29: 755-76.
15. The non-Hodgkin's lymphoma pathologic classification project. National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas: summary and description of a working formulation for clinical usage. Cancer (Phila) 1982; 49: 2112-35.
16. Harris NL, Jaffe ES, Stein H, Banks PM, Chan JKC, Cleary ML, Delsol G, De Wolf-Peeters C, Falini B, Garter KC, Grogan TM, Isaacson PG, Knowles DM, Mason DY, Muller-Hennelink H-K, Pileri SA, Piris MA, Ralfkiaer E, Warnke RA. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994; 84: 1361-92.
17. Zhang S-J, Endo S, Koga H, Ichikawa T, Feng X-L, Onda K, Washiyama K, Kumanishi T. A comparative study of glioma cell lines for p16, p15, p53 and p21 gene alterations. Jpn J Cancer Res 1996; 87: 900-7.
18. Sanger F, Nicklen S, Coulson AR. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA 1977; 74 5463-7.
19. Merlo A, Herman JG, Mao L, Lee DJ, Gabrielson E, Burger PC, Baylin SB, Sidransky D. 5′CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers. Nat Med 1995; 1: 686-92.
20. INK4a genes in primary central nervous system lymphomas. Cancer Res 2001; 61: 6335-9.
21. Rizos H, Puig S, Badenas C, Malvehy J, Darmanian AP, Jiménez L, Mila M, Kefford RF. A melanoma-associated germline mutation in exon 1β inactivates p14ARF. Oncogene 2001; 20: 5543-7.
22. ARF peptide blocks Mdm2-dependent ubiquitination in vitro and can activate p53 in vivo. Oncogene 2000; 19: 2312-23.
23. Rizos H, Darmanian AP, Mann GJ, Kefford RF. Two arginine rich domains in the p14ARF tumor suppressor mediate nucleolar localization. Oncogene 2000; 19: 2978-85.
24. Gonzalez-Gomez P, Bello MJ, Arjona D, Alonso ME, Lomas J, Amiñoso C, de Campos JM, Sarasa JL, Gutierrez M, Rey JA. CpG island methylation of tumor-related genes in three primary central nervous system lymphomas in immunocompetent patients. Cancer Genet Cytogenet 2003; 142: 21-4.
25. Pinyol M, Hernández L, Martínez A, Cobo F, Hernández S, Beà S, López-Guillermo A, Nayach I, Palacín A, Nadal A, Fernández PL, Montserrat E, Cardesa A, Campo E. INK4a /ARF locus alterations in human non-Hodgkin's lymphomas mainly occur in tumors with wild-type p53 gene. Am J Pathol 2000; 156: 1987-96.
26. INK4a (MTS1) in B-cell and T-cell lymphomas. Blood 1999; 94: 1773-81.
27. Koga H, Zhang S-J, Ichikawa T, Washiyama K, Kuroiwa T, Tanaka R, Kumanishi T. Primary malignant lymphoma of the brain: Demonstration of the p53 gene mutations by PCR-SSCP analysis and immunohistochemistry. Brain Tumor Pathol 1994; 11: 151-5.